Trial
NCT05694741
A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Type 2 Diabetes
Intervention
AZD0186
Why stopped
The decision was based on the overall data profile obtained from this study which did not demonstrate sufficient differentiation to surpass the current standard of care.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-13